Steris | STE - Cash And Equivalent

Stock Price
221.80
Daily Change
-1.72 -0.77%
Monthly
-0.71%
Yearly
-1.42%
Q2 Forecast
217.05

Steris reported $423.7M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
3M USD 3.73B 1.51B Mar/2026
Accuray USD 63.34M 5.93M Sep/2025
Avanos Medical USD 89.8M 19.3M Dec/2025
Baxter International USD 1.97B 240M Dec/2025
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Boston Scientific USD 1.96B 690M Dec/2025
CONMED USD 38.93M 4.99M Sep/2025
Cooper Companies USD 110.6M 14.3M Sep/2025
Dexcom USD 917.7M 918M Dec/2025
Ecolab USD 646.2M 1.31B Dec/2025
Edwards Lifesciences USD 2.4B 538M Mar/2026
Fortive USD 375.5M 55.3M Dec/2025
Getinge SEK 2.96B 720M Dec/2024
Globus Medical USD 526.16M 154.39M Dec/2025
Haemonetics USD 363.37M 66.94M Dec/2025
Idexx Laboratories USD 180.07M 28.1M Dec/2025
Inogen USD 106.48M 2.79M Sep/2025
Insulet USD 716.1M 41.3M Dec/2025
Integra LifeSciences USD 235.05M 2.86M Dec/2025
Intuitive Surgical USD 7.98B 1.05B Mar/2026
J&J USD 21.69B 1.98B Mar/2026
Masimo USD 312.3M 162.7M Sep/2025
Olympus JPY 147.24B 93.98B Sep/2025
Orthofix International USD 82.02M 19.16M Dec/2025
Owens Minor USD 281.99M 249.15M Dec/2025
ResMed USD 1.42B 33.22M Dec/2025
Steris USD 423.7M 104.5M Dec/2025
Stryker USD 4.01B 755M Dec/2025
Tandem Diabetes Care USD 90.63M 1.31M Dec/2025
Teleflex USD 354M 100.3M Sep/2025
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Zimmer Biomet Holdings USD 591.9M 700.8M Dec/2025